Loading Events

« All Events

  • This event has passed.

An Author Webinar on the Neuropathic Pain Symptom Inventory (NPSI) for Clinical Research Assessment of Patient Pain

September 15, 2016 1:00 pm - 2:00 pm

Webinar Topic:

An Author Webinar on the Neuropathic Pain Symptom Inventory (NPSI) for Clinical Research Assessment of Patient Pain

Webinar Date/Time:

Thursday, September 15, 2016 at

  • 1:00 pm, EST (New York, USA)
  • 6:00 pm, GMT (London, UK)
  • 7:00 pm, CET (Paris, FR)

Webinar Host:


Dr. Didier Bouhassira, MD, PhD –

  • NPSI Questionnaire Author
  • Neurologist (AP-HP)
  • INSERM Director
  • Vice President of the SFETD

marie d

Marie Dulac Trimoreau, MSc –

  • Author Relations Specialist, Mapi Research Trust

Webinar Description:

The Neuropathic Pain Symptom Inventory (NPSI) Questionnaire’s objective:

  • To evaluate the different symptoms of neuropathic pain

Therapeutic area(s) of focus:

  • Nervous System Diseases
  • Pathological Conditions, Signs and Symptoms
  • Psychological Phenomena and Processes
  • Musculoskeletal and Neural Physiological Phenomena

Therapeutic indication:

  • Pain

Type of Clinical Outcome Assessment (COA):

  • PRO

General Summary of the NPSI:

  • “The NPSI allows discrimination and qua:ntification of the distinct and clinically relevant dimensions of neuropathic pain syndromes (spontaneous ongoing pain, spontaneous paroxysmal pain, evoked pain, and paresthesia/dysesthesia) that are sensitive to treatment. The pain may be burning, squeezing, or pressure in character. The burning pain represents the superficial component, whereas pressure and squeezing pain represent the deep component of the spontaneous ongoing pain. The authors recommended usage of the psychometric properties of the NPSI to characterize subgroups of neuropathic pain patients and to verify the response of the patients to various pharmacologic agents or interventions.
  • The final version of the NPSI includes 12 items; 10 are descriptors of the different symptoms, and assess the duration of spontaneous ongoing and paroxysmal pain. A total intensity score is calculated as the sum of the scores of the 10 descriptors. Increases or decreases in the NPSI total score are related to changes in the patient’s pain.
  • An English version of the NPSI is available. The NPS and NPSI evaluate the symptoms of patients with neuropathic pain, determine the efficacy of different treatments, and help elucidate the mechanism(s) of effect of such treatments. The NPS and NPSI do not differentiate patients with neuropathic pain from patients with non-neuropathic pain,” (source).


Register now to gain an insider-perspective based on all Dr. Bouhassira, NPSI Author, has to show and tell you about his screening tool for clinical researchers:

To learn more about this screening tool instead of registering for this webinar, visit the Mapi Research Trust (MRT) licensed NPSI instrument’s webpage listing on our ePROVIDE database: